Program at a Glance

Day 1 (May 7, Thu)
Day 1 (May 7, Thu)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 2+3)
Room C
(Grand Hall 1)
12:30-13:00 Registration
13:00-13:10 Opening
13:10-13:50 Plenary Lecture I The Global Burden of Allergic Diseases:
WAO Strategies for a Healthier Future
13:50-14:10 Coffee Break
14:10-15:40 KAAACI-WAO Symposium Global Strategies for Allergy: From Early Origins to Future Management Symposium I Advances in Hypereosinophilic Disorders KOR KAAACI-KATRD Airway Symposium
15:40-16:00 Break
16:00-17:30 Symposium II Multidimensional Drivers of Atopic Dermatitis: Biology, Microbiome Ecology, Environment Working Group Symposium I Neurobiology of Chronic Cough: Translating Science into Clinical Impact KOR KAAACI-KATRD Airway Symposium
17:30-17:50 Break
17:50-18:30 Sponsored Symposium I
(GSK Korea) The Clinical Impact of IL-5 Inhibition in Severe Eosinophilic Asthma: Can Mepolizumab Modify Disease Course?
Sponsored Symposium II
(Novartis Korea) Closing the Gap in CSU: The Promise of BTK Inhibition
Sponsored Symposium III
(Takeda) Beyond Attacks: Disease Control in HAE with Lanadelumab
Day 2 (May 8, Fri)
Day 2 (May 8, Fri)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 2+3)
Room C
(Grand Hall 1)
Room D
(Grand Hall 4+5)
09:00-09:40 Plenary Lecture II Viral Exacerbations of Asthma and COPD: Shared Triggers, Distinct Pathogenesis
09:40-10:20 Plenary Lecture III Treatable Traits in Severe Airway Disease: A Personalized Approach to Biologics
10:20-10:40 Coffee Break
10:40-12:10 KAAACI-EAACI Symposium Precision Approaches in Allergen Immunotherapy: From Evidence to Real-World Practice KAAACI-Interasma Symposium I Heterogeneity in Severe Asthma: Omics-Driven Insights and Evolving Endotypes Symposium III Allergic Rhinitis and Chronic Rhinosinusitis: Evolving Mechanisms and Targeted Therapeutic Strategies KORSymposium IV Artificial Intelligence in Allergy & Immunology: From Fundamentals to Precision Medicine
12:10-12:20 Break
12:20-13:00 Sponsored Symposium IV
(Sanofi-Aventis Korea) Rethinking Asthma Manangement with Dupilumab: Insights into Airway Remodeling
Sponsored Symposium V
(Celltrion Pharm)Introduction of 1st Omalizumab Biosimilar (Omlycolo) and Treatment Strategy for CSU
Sponsored Symposium VI
(GSK Korea)Redefining Asthma Management Goals: Moving Beyond "Control" to "Clinical Remission" (TBC)
13:00-13:50 Break & Poster Discussion (Q&A) I
13:50-14:30 Plenary Lecture IV Unraveling the Heterogeneity of Chronic Urticaria: From Pathogenesis to Precision Medicine
14:30-14:50 Break
14:50-16:20 Oral Presentation I Oral Presentation II KORAllied Health Professional (AHP) Symposium KOROral Presentation III
16:20-16:30 Break Break
16:30-18:00 KAACI-AAIAT Symposium Real-World Evidence of Allergic Diseases in the Asia-Pacific Region Symposium V Updates in Chronic Urticaria: Pathogenesis, Comorbidities, and Treatment Beyond Omalizumab KORHealthcare Policy Directions for Severe Asthma in Korea
KORPublic Hearing on Guidelines for Biologics in Severe Asthma
18:00-18:40 Sponsored Symposium VII
(AstraZeneca Korea) Filling the Gap: From Downstream to Upstream Targets in Severe Asthma
Sponsored Symposium VIII
(Sanofi-Aventis Korea) Latest Scientific Updates in CRSwNP: Focusing on Type 2 inflammation and Asthma Comorbidity
Sponsored Symposium Ⅸ
(Lilly Korea) EBGLYSS 4U: Turn AD Down and Keep It Down
18:40-20:00 KAAACI Ceremony & Gala Dinner (Walker Hall, 1F)
Day 3 (May 9, Sat)
Day 3 (May 9, Sat)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 2+3)
Room C
(Grand Hall 1)
Room D
(Grand Hall 4+5)
07:30-08:30 Meet the Expert I
(Grand Hall 4)
Meet the Expert II
(Grand Hall 5)
Meet the Expert III
(Grand Hall 6)
Meet the Expert Ⅳ
(Pine Room)
08:30-09:00 Break
09:00-09:40 Plenary Lecture V Delabeling Drug Allergy: A Global Strategy for Antimicrobial Stewardship and Patient Safety
09:40-10:20 Plenary Lecture VI Central Mechanisms of Chronic Cough Hypersensitivity
10:20-10:40 Coffee Break
10:40-12:10 Oral Presentation IV Oral Presentation V KOR Oral Presentation VI
12:10-12:20 Break
12:20-13:00 Sponsored Symposium Ⅹ
(Novartis Korea) BTK Inhibitor in CU: Clinical Outcomes and Lessons from Early Real-World Use
Sponsored Symposium XI
(AstraZeneca Korea) Precision Medicine in Severe Eosinophilic Asthma: Role of Benralizumab
Sponsored Symposium XII
(Celltrion Pharm) Definition and Characteristics of Biosimilar, Clinical Use Experience
13:00-13:50 Break & Poster Discussion(Q&A) II
13:50-14:30 Plenary Lecture VII Precision Medicine for HES: From Phenotype to Genotype
14:30-14:50 Break
14:50-16:20 KAAACI-Interasma Symposium II Severe Asthma Linking Endotypes to Airway Remodeling Working Group Symposium II Hypersensitivity to Cancer Therapies and Biologic Agents KOR Symposium VI Integrating National Research and Registry Data to Advance Asthma Care Across the Lifespan
16:20-16:30 KAAACI Award Ceremony & Closing

위로 가기